Ligand validation:5GNZ

BGC: beta-D-glucopyranose

BGC is a Ligand Of Interest in 5GNZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5GNZ_BGC_A_501	23%	48%	0.246	0.869	0.76	1.23	-	2	3	0	100%	0.8067
5GNZ_BGC_J_501	20%	60%	0.303	0.907	0.75	0.77	-	-	2	0	100%	0.81
5GNZ_BGC_H_502	17%	55%	0.303	0.887	0.72	1.02	-	1	2	0	100%	0.7633
5GNZ_BGC_K_501	16%	59%	0.302	0.877	0.78	0.81	-	-	3	0	100%	0.725
5GNZ_BGC_I_501	16%	52%	0.329	0.904	0.78	1.07	-	1	2	0	100%	0.7717
5GNZ_BGC_D_501	15%	42%	0.342	0.906	0.59	1.64	-	4	2	0	100%	0.8392
5GNZ_BGC_B_501	11%	56%	0.33	0.853	0.76	0.92	-	1	2	0	100%	0.7667
5GNZ_BGC_C_501	6%	61%	0.417	0.847	0.77	0.73	-	-	2	0	100%	0.7467
5GNX_BGC_A_502	53%	46%	0.119	0.879	0.79	1.27	-	1	3	0	100%	1
5GNY_BGC_A_501	44%	43%	0.191	0.921	0.59	1.58	-	2	2	0	100%	0.6875
1HHU_BGC_C_8	100%	67%	0.037	0.997	0.6	0.68	-	-	0	0	100%	0.9167
2V3G_BGC_A_1281	100%	68%	0.051	0.994	0.52	0.69	-	-	0	0	100%	1
3ACT_BGC_B_3901	99%	47%	0.05	0.988	0.92	1.12	-	1	0	0	100%	1
3AFJ_BGC_A_2901	99%	59%	0.054	0.989	0.59	0.96	-	1	0	0	100%	1
7D9C_BGC_A_611	98%	40%	0.056	0.981	0.91	1.43	-	3	1	0	100%	0.318

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.